Nuvation Bio IncNYSE:NUVB
- LAST PRICE2.9900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.0200/ 15
- Ask / Lots3.1400/ 4
- Open / Previous Close0.0000 / 2.9900
- Day Range---
- 52 Week Range
- Volume20
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NUVB |
|---|---|---|
| 09:32 ET | 1481 | 3.14 |
| 09:34 ET | 129978 | 3.228 |
| 09:36 ET | 23689 | 3.14 |
| 09:38 ET | 25977 | 3.09 |
| 09:39 ET | 3922 | 3.08 |
| 09:41 ET | 15781 | 3.065 |
| 09:43 ET | 10408 | 3.065 |
| 09:45 ET | 10265 | 3.0999 |
| 09:48 ET | 4822 | 3.1 |
| 09:50 ET | 1000 | 3.105 |
| 09:52 ET | 11782 | 3.095 |
| 09:54 ET | 5236 | 3.085 |
| 09:56 ET | 13782 | 3.115 |
| 09:57 ET | 24545 | 3.14 |
| 09:59 ET | 980 | 3.148 |
| 10:01 ET | 40937 | 3.105 |
| 10:03 ET | 10502 | 3.1 |
| 10:06 ET | 8646 | 3.135 |
| 10:08 ET | 11172 | 3.125 |
| 10:10 ET | 700 | 3.125 |
| 10:12 ET | 6467 | 3.125 |
| 10:14 ET | 9925 | 3.105 |
| 10:15 ET | 2865 | 3.105 |
| 10:17 ET | 9732 | 3.095 |
| 10:19 ET | 6096 | 3.095 |
| 10:21 ET | 1796 | 3.095 |
| 10:24 ET | 2333 | 3.095 |
| 10:26 ET | 13130 | 3.08 |
| 10:28 ET | 8294 | 3.085 |
| 10:30 ET | 1500 | 3.085 |
| 10:32 ET | 8787 | 3.095 |
| 10:33 ET | 9277 | 3.075 |
| 10:35 ET | 6779 | 3.055 |
| 10:37 ET | 34582 | 3.08 |
| 10:39 ET | 6420 | 3.06 |
| 10:42 ET | 4035 | 3.07 |
| 10:44 ET | 1000 | 3.07 |
| 10:46 ET | 4580 | 3.08 |
| 10:48 ET | 1200 | 3.08 |
| 10:50 ET | 1500 | 3.075 |
| 10:51 ET | 13286 | 3.055 |
| 10:53 ET | 2536 | 3.055 |
| 10:55 ET | 1000 | 3.055 |
| 10:57 ET | 1184 | 3.06 |
| 11:00 ET | 19165 | 3.0585 |
| 11:02 ET | 7929 | 3.07 |
| 11:04 ET | 5974 | 3.055 |
| 11:06 ET | 1500 | 3.05 |
| 11:08 ET | 2000 | 3.055 |
| 11:09 ET | 2948 | 3.055 |
| 11:11 ET | 1900 | 3.05 |
| 11:13 ET | 26378 | 3.04 |
| 11:15 ET | 750 | 3.035 |
| 11:18 ET | 4158 | 3.045 |
| 11:20 ET | 900 | 3.045 |
| 11:22 ET | 3135 | 3.06 |
| 11:24 ET | 1500 | 3.05 |
| 11:26 ET | 1600 | 3.055 |
| 11:27 ET | 1800 | 3.055 |
| 11:29 ET | 1200 | 3.055 |
| 11:31 ET | 1200 | 3.055 |
| 11:33 ET | 7931 | 3.045 |
| 11:36 ET | 500 | 3.045 |
| 11:38 ET | 1200 | 3.04 |
| 11:40 ET | 8655 | 3.055 |
| 11:42 ET | 716 | 3.06 |
| 11:44 ET | 1260 | 3.055 |
| 11:45 ET | 3948 | 3.07 |
| 11:47 ET | 1200 | 3.07 |
| 11:49 ET | 3815 | 3.08 |
| 11:51 ET | 1200 | 3.08 |
| 11:54 ET | 817 | 3.075 |
| 11:56 ET | 1739 | 3.075 |
| 11:58 ET | 3661 | 3.09 |
| 12:00 ET | 1248 | 3.085 |
| 12:02 ET | 4534 | 3.075 |
| 12:03 ET | 903 | 3.07 |
| 12:05 ET | 16211 | 3.08 |
| 12:07 ET | 1842 | 3.085 |
| 12:09 ET | 1938 | 3.09 |
| 12:12 ET | 5022 | 3.08 |
| 12:14 ET | 500 | 3.07 |
| 12:16 ET | 4602 | 3.06 |
| 12:18 ET | 2115 | 3.06 |
| 12:20 ET | 400 | 3.06 |
| 12:21 ET | 1826 | 3.0603 |
| 12:23 ET | 810 | 3.06 |
| 12:25 ET | 2511 | 3.06 |
| 12:27 ET | 900 | 3.065 |
| 12:30 ET | 13793 | 3.055 |
| 12:32 ET | 1182 | 3.055 |
| 12:34 ET | 3732 | 3.0559 |
| 12:36 ET | 1114 | 3.06 |
| 12:38 ET | 1400 | 3.05 |
| 12:39 ET | 5650 | 3.05 |
| 12:41 ET | 1327 | 3.045 |
| 12:43 ET | 5565 | 3.055 |
| 12:45 ET | 700 | 3.055 |
| 12:48 ET | 634 | 3.055 |
| 12:50 ET | 2600 | 3.05 |
| 12:52 ET | 1000 | 3.06 |
| 12:54 ET | 2700 | 3.055 |
| 12:56 ET | 2240 | 3.055 |
| 12:57 ET | 800 | 3.06 |
| 12:59 ET | 1400 | 3.06 |
| 01:01 ET | 3405 | 3.04 |
| 01:03 ET | 1100 | 3.04 |
| 01:06 ET | 1600 | 3.04 |
| 01:08 ET | 7229 | 3.04 |
| 01:10 ET | 7449 | 3.035 |
| 01:12 ET | 2000 | 3.03 |
| 01:14 ET | 1952 | 3.035 |
| 01:15 ET | 300 | 3.035 |
| 01:17 ET | 1500 | 3.03 |
| 01:19 ET | 37346 | 3.01 |
| 01:21 ET | 5419 | 3.005 |
| 01:24 ET | 1924 | 3 |
| 01:26 ET | 1200 | 3 |
| 01:28 ET | 1200 | 3.005 |
| 01:30 ET | 1500 | 3 |
| 01:32 ET | 18955 | 3 |
| 01:33 ET | 200 | 3.005 |
| 01:35 ET | 700 | 3 |
| 01:37 ET | 11922 | 2.995 |
| 01:39 ET | 21679 | 3 |
| 01:42 ET | 5810 | 2.99 |
| 01:44 ET | 100 | 2.99 |
| 01:46 ET | 300 | 2.99 |
| 01:48 ET | 4832 | 2.99 |
| 01:50 ET | 18124 | 2.98 |
| 01:51 ET | 300 | 2.985 |
| 01:53 ET | 4432 | 2.985 |
| 01:55 ET | 800 | 2.98 |
| 01:57 ET | 2323 | 2.98 |
| 02:00 ET | 1535 | 2.985 |
| 02:02 ET | 14903 | 2.995 |
| 02:06 ET | 18816 | 2.99 |
| 02:08 ET | 3197 | 2.995 |
| 02:09 ET | 300 | 2.99 |
| 02:11 ET | 238 | 2.995 |
| 02:13 ET | 200 | 2.995 |
| 02:15 ET | 775 | 2.9941 |
| 02:18 ET | 1000 | 2.995 |
| 02:20 ET | 6034 | 2.99 |
| 02:22 ET | 800 | 2.995 |
| 02:24 ET | 400 | 2.995 |
| 02:26 ET | 1593 | 3 |
| 02:27 ET | 28386 | 2.995 |
| 02:29 ET | 1130 | 3 |
| 02:31 ET | 12526 | 2.995 |
| 02:33 ET | 26775 | 3 |
| 02:36 ET | 13206 | 3.015 |
| 02:38 ET | 4434 | 3.0299 |
| 02:40 ET | 600 | 3.025 |
| 02:42 ET | 2100 | 3.02 |
| 02:44 ET | 700 | 3.02 |
| 02:45 ET | 6599 | 3.025 |
| 02:47 ET | 700 | 3.02 |
| 02:49 ET | 3289 | 3.025 |
| 02:51 ET | 1608 | 3.02 |
| 02:54 ET | 500 | 3.025 |
| 02:56 ET | 1200 | 3.02 |
| 02:58 ET | 7094 | 3.015 |
| 03:00 ET | 15540 | 3.01 |
| 03:02 ET | 14571 | 2.985 |
| 03:03 ET | 5000 | 2.985 |
| 03:05 ET | 500 | 2.985 |
| 03:07 ET | 1600 | 2.985 |
| 03:09 ET | 100 | 2.985 |
| 03:12 ET | 6780 | 3 |
| 03:14 ET | 1099 | 2.99 |
| 03:16 ET | 1600 | 2.995 |
| 03:18 ET | 900 | 2.995 |
| 03:20 ET | 7533 | 2.985 |
| 03:21 ET | 276 | 2.9886 |
| 03:23 ET | 700 | 2.985 |
| 03:25 ET | 203 | 2.985 |
| 03:27 ET | 9720 | 2.995 |
| 03:30 ET | 740 | 2.995 |
| 03:32 ET | 1200 | 3 |
| 03:34 ET | 1639 | 3 |
| 03:36 ET | 1463 | 3 |
| 03:38 ET | 1666 | 3 |
| 03:39 ET | 19885 | 2.995 |
| 03:41 ET | 3682 | 2.995 |
| 03:43 ET | 17823 | 2.985 |
| 03:45 ET | 3800 | 2.99 |
| 03:48 ET | 4092 | 2.99 |
| 03:50 ET | 3927 | 2.985 |
| 03:52 ET | 9263 | 2.985 |
| 03:54 ET | 10378 | 2.99 |
| 03:56 ET | 30934 | 2.98 |
| 03:57 ET | 16477 | 2.985 |
| 03:59 ET | 137629 | 2.99 |
Jun 3, 2024
DJ Nuvation Bio Price Target Maintained With a $8.00/Share by HC Wainwright & Co., from 6:46AM ET on Monday Jun 03, 2024 by Dow Jones
6:46AM ET on Monday Jun 03, 2024 by Dow Jones
Jun 1, 2024
Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting, from 8:10AM ET on Saturday Jun 01, 2024 by Dow Jones
8:10AM ET on Saturday Jun 01, 2024 by Dow Jones
May 29, 2024
Nuvation Bio to Present at the Jefferies Global Healthcare Conference, from 4:05PM ET on Wednesday May 29, 2024 by Dow Jones
4:05PM ET on Wednesday May 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nuvation Bio Inc | 739.0M | -9.5x | --- |
89Bio Inc | 719.2M | -3.6x | --- |
ARS Pharmaceuticals Inc | 782.9M | -15.5x | --- |
Viridian Therapeutics Inc | 785.7M | -2.7x | --- |
Mesoblast Ltd | 736.0M | -4.6x | --- |
CARGO Therapeutics Inc | 683.1M | -5.0x | --- |
Company Information
Nuvation Bio Inc. is a biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. The Company is advancing multiple clinical-stage candidates, including a ROS1 inhibitor, a mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor, a bromodomain and extra-terminal (BET) inhibitor, and a drug-drug conjugate (DDC). Its portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Taletrectinib is an oral, potent, CNS-active, selective, ROS1 inhibitor specifically designed for the potential treatment of ROS1-positive non-small cell lung cancer (NSCLC). Safusidenib is an oral, potent, targeted inhibitor of mIDH1 being evaluated in a global Phase II trial in patients with low-grade IDH1-mutant glioma. NUV-868 is a BD2-selective oral small molecule BET inhibitor, that inhibits BRD4. It is conducting Phase I/II study of NUV-1511.
Contact Information
- Headquarters
- 357 Tehama Street, Floor 3SAN FRANCISCO, CA, United States 94103
- Phone
- 415-754-3517
- Fax
- 302-636-5454
Executives
- Independent Chair of the Board
- Daniel Welch
- President, Chief Executive Officer, Founder, Director
- David Hung
- Principal Financial and Accounting Officer, Vice President - Finance
- Moses Makunje
- Chief Executive Officer of AnHeart Therapeutics and Director
- Junyuan Wang
- Chief People Officer
- Stacy Markel
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $739.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 247.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.40 |
EPS | $-0.31 |
Book Value | $2.76 |
P/E Ratio | -9.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
